DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Abramson J, Gordon L, Palomba ML. et al.
Updated safety and long‐term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.
J Clin Oncol 2018;
36 (15) 7505
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.